Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04637815 · ClinicalTrials.gov registry record · Phase 1
A Social Network AOD Intervention for Homeless Youth Transitioning to Housing
A Phase 1 study, sponsored by RAND.
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT04637815: Completed Phase 1 study, sponsored by RAND.
NCT04637815 is a Phase 1 study that has completed, run by RAND. The registered enrollment target is 39 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (35% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04637815, a Phase 1 study, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
This project will pilot test a computer-assisted social network intervention, using motivational interviewing techniques, that can help case managers work with formerly homeless young adults who recently transitioned to supportive housing to reduce substance use and increase permanent supportive connections during this critical transitional period.
Primary Outcome
Count of days that respondent used cannabis in the past 30 days
Interventions
- OTHER Usual Care
- BEHAVIORAL Motivational Network Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2021-02-09 |
| Est. Completion | 2023-09-01 |
| Phase | Phase 1 |
What the finished NCT04637815 record still lists
NCT04637815 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (35% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT04637815 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04637815 about?
NCT04637815 is a clinical study titled "A Social Network AOD Intervention for Homeless Youth Transitioning to Housing". This project will pilot test a computer-assisted social network intervention, using motivational interviewing techniques, that can help case managers work with formerly homeless young adults who recently transitioned to supportive housing to reduce substance use and increase permanent supportive con...
What is the current status of trial NCT04637815?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2021-02-09. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT04637815?
The interventions under investigation include: Usual Care (OTHER), Motivational Network Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04637815?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04637815's enrollment target sits among peer trials
39 1191st of 2000 higher than 804 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI